PubRank

C E Rubens

Author PubWeight™ 77.97‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother 1984 4.25
2 Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun 1997 2.97
3 A case-control study of necrotizing fasciitis during primary varicella. Pediatrics 1999 2.54
4 The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon. J Bacteriol 2000 2.45
5 Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus. Mol Microbiol 2001 2.28
6 Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun 1996 2.25
7 Evolution of a plasmid mediating resistance to multiple antimicrobial agents during a prolonged epidemic of nosocomial infections. J Infect Dis 1981 2.13
8 Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci U S A 1989 2.13
9 Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995 2.04
10 New genetic techniques for group B streptococci: high-efficiency transformation, maintenance of temperature-sensitive pWV01 plasmids, and mutagenesis with Tn917. Appl Environ Microbiol 1997 2.04
11 Group B streptococci invade endothelial cells: type III capsular polysaccharide attenuates invasion. Infect Immun 1993 2.01
12 Blue/white screening of recombinant plasmids in Gram-positive bacteria by interruption of alkaline phosphatase gene (phoZ) expression. Gene 1998 1.87
13 Transposable plasmid deoxyribonucleic acid sequence in Pseudomonas aeruginosa which mediates resistance to gentamicin and four other antimicrobial agents. J Bacteriol 1979 1.85
14 Lung antibacterial defense mechanisms in infant and adult rats: implications for the pathogenesis of group B streptococcal infections in the neonatal lung. J Infect Dis 1988 1.82
15 A virulent nonencapsulated Haemophilus influenzae. J Infect Dis 1996 1.73
16 Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis. Mol Microbiol 2000 1.69
17 Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect Immun 1994 1.63
18 Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells. Infect Immun 1993 1.63
19 Group B streptococci adhere to a variant of fibronectin attached to a solid phase. Mol Microbiol 1995 1.63
20 Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect Immun 1992 1.56
21 Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect Immun 2000 1.52
22 Evolution of multiple-antibiotic-resistance plasmids mediated by transposable plasmid deoxyribonucleic acid sequences. J Bacteriol 1979 1.44
23 Genetic loci of Streptococcus mitis that mediate binding to human platelets. Infect Immun 2001 1.38
24 Molecular analysis of a region of the group B streptococcus chromosome involved in type III capsule expression. Infect Immun 1989 1.38
25 Group B streptococcal beta-hemolysin promotes injury of lung microvascular endothelial cells. Pediatr Res 1999 1.26
26 Regulation of purine biosynthesis by a eukaryotic-type kinase in Streptococcus agalactiae. Mol Microbiol 2005 1.22
27 Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells In vitro. Infect Immun 1998 1.19
28 Production of tumor necrosis factor by human cells in vitro and in vivo, induced by group B streptococci. J Pediatr 1993 1.18
29 Evolution of antimicrobial resistance and nosocomial infection. Lessons from the Vanderbilt experience. Am J Med 1981 1.18
30 Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Pediatr Infect Dis J 1996 1.13
31 The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats. J Infect Dis 1992 1.13
32 Characterization of cpsF and its product CMP-N-acetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in K1 capsular polysaccharide biosynthesis in Escherichia coli. Mol Microbiol 1996 1.10
33 A role for C5 and C5a-ase in the acute neutrophil response to group B streptococcal infections. J Infect Dis 1997 1.09
34 Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression. J Bacteriol 2005 1.06
35 Use of a dental amalgamator to extract RNA from the gram-positive bacterium Streptococcus agalactiae. Biotechniques 1997 1.06
36 NeuD plays a role in the synthesis of sialic acid in Escherichia coli K1. FEMS Microbiol Lett 2000 1.06
37 Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun 2000 1.03
38 Analysis of restriction fragment length polymorphisms of the insertion sequence IS1381 in group B Streptococci. J Infect Dis 2000 1.01
39 Cloning and expression in Escherichia coli of a gene encoding nonenzymatic chloramphenicol resistance from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1986 1.01
40 Differentiation of cultured keratinocytes promotes the adherence of Streptococcus pyogenes. J Clin Invest 1998 0.99
41 Transposon mutagenesis of group B streptococcus beta-hemolysin biosynthesis. Infect Immun 1987 0.97
42 Use of nonhuman primate models to investigate mechanisms of infection-associated preterm birth. BJOG 2010 0.94
43 The role of group B streptococci beta-hemolysin expression in newborn lung injury. Adv Exp Med Biol 1997 0.94
44 Analysis of the capsule synthesis locus, a virulence factor in group B streptococci. Adv Exp Med Biol 1997 0.94
45 Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation. FASEB J 2009 0.93
46 Characterization of Enterococcus faecalis alkaline phosphatase and use in identifying Streptococcus agalactiae secreted proteins. J Bacteriol 1999 0.91
47 Characteristics of gentamicin resistance in nosocomial infections. Am J Med Sci 1980 0.88
48 Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells. Infect Immun 1995 0.87
49 Isogenic group B streptococci devoid of capsular polysaccharide or beta-hemolysin: pulmonary hemodynamic and gas exchange effects during bacteremia in piglets. Pediatr Res 1989 0.83
50 NSAIDS and necrotizing fasciitis. Pediatr Infect Dis J 1999 0.83
51 Bacterial evasion of the antibody response: human IgG antibodies neutralize soluble but not bacteria-associated group B streptococcal C5a-ase. J Infect Dis 1992 0.81
52 Tumor necrosis factor-alpha and interleukin-1alpha decrease the adherence of Streptococcus pyogenes to cultured keratinocytes. J Infect Dis 1999 0.81
53 Role of keratinocyte injury in adherence of Streptococcus pyogenes. Infect Immun 1999 0.79
54 Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin. J Infect Dis 1980 0.77
55 DNA restriction profiles of nontypable group B streptococcal clinical isolates. Adv Exp Med Biol 1997 0.75
56 Pharmacokinetic and pharmacodynamic analysis of a human immunoglobulin M monoclonal antibody in neonatal Macaca fascicularis. Pediatr Res 1991 0.75